thbs3a Antibody

What is THBS3 and why is it important in research?

THBS3 (Thrombospondin-3) is an adhesive glycoprotein that mediates critical cell-to-cell and cell-to-matrix interactions in the extracellular environment . It can bind to several important molecules including fibrinogen, fibronectin, laminin, and type V collagen . The protein plays crucial roles in tissue development, homeostasis, and various cellular processes including cell adhesion, migration, and signaling pathways . THBS3 research is particularly important because its dysregulation has been linked to multiple pathological conditions including cancer, cardiovascular disorders, and fibrosis . Studying THBS3 using specific antibodies enables researchers to understand fundamental biological processes and potentially identify novel therapeutic targets for these diseases.

What types of THBS3 antibodies are available for research applications?

Several types of THBS3 antibodies are available for research applications, primarily polyclonal antibodies produced in rabbits. Examples include the THBS3 Polyclonal Antibody (PACO30378), which is reactive with mouse samples and has been validated for ELISA applications . Another option is the Thrombospondin-3 Polyclonal Antibody (CAB3641), which shows reactivity with both mouse and rat samples and has been validated for Western blot and ELISA techniques . These antibodies target different regions of the THBS3 protein - for instance, CAB3641 recognizes a sequence corresponding to amino acids 787-956 of human THBS3 . The selection of an appropriate antibody depends on the specific research application, target species, and experimental technique being employed.

How should THBS3 antibodies be stored and handled to maintain optimal activity?

THBS3 antibodies should be stored according to manufacturer specifications to maintain their activity and specificity. For example, the THBS3 Polyclonal Antibody (PACO30378) is supplied in liquid form and should be stored in a storage buffer containing 0.03% Proclin 300, 50% Glycerol, and 0.01M PBS at pH 7.4 . This formulation helps preserve antibody stability and function. For long-term storage, antibodies should typically be kept at -20°C, while working aliquots can be stored at 4°C for shorter periods to minimize freeze-thaw cycles that could degrade antibody quality. When handling, researchers should avoid contamination, extended exposure to room temperature, and excessive vortexing that might denature the antibody protein structure. Always follow specific manufacturer guidelines for each antibody product to ensure optimal performance in experimental applications.

How can THBS3 antibodies be used to investigate viral infection mechanisms?

THBS3 antibodies have proven valuable in investigating viral infection mechanisms, particularly with pseudorabies virus (PRV). Research has revealed that THBS3 functions as a novel coreceptor for PRV entry into target cells . Methodologically, researchers can employ THBS3 antibodies in blocking assays to inhibit viral infection in cell culture models. For example, studies have demonstrated that THBS3 antibodies significantly block PRV infection in vitro without affecting cell viability . This approach involves pretreating cells with THBS3 polyclonal antibodies at appropriate concentrations before viral challenge. Additionally, THBS3 antibodies can be used in co-immunoprecipitation experiments to confirm direct binding between THBS3 and viral glycoproteins like PRV gD . Immunofluorescence assays with THBS3 antibodies also help visualize the localization of THBS3 during viral attachment and entry phases. These applications collectively provide insights into how THBS3 contributes to viral binding, fusion, and entry processes.

What experimental controls should be included when using THBS3 antibodies for functional studies?

When designing functional studies using THBS3 antibodies, several critical controls should be incorporated to ensure valid and interpretable results. First, researchers should include isotype controls (using the same antibody class but with irrelevant specificity) to distinguish specific binding from nonspecific background signals. Second, concentration-dependent experiments should be performed to establish optimal antibody concentrations that provide specific blocking without cytotoxicity. Cytotoxicity assays, as described in the PRV infection studies, should verify that antibody concentrations used do not affect cell viability . For genetic manipulation studies, appropriate vector-only controls should be included alongside THBS3 overexpression or knockout models . When using THBS3 antibodies for blocking studies, both pre-immune serum controls and competitive binding with recombinant THBS3 protein can validate specificity. Finally, multiple detection methods (e.g., Western blot and immunofluorescence) should be employed to corroborate findings, particularly when investigating novel THBS3 functions or interactions.

How can CRISPR-Cas9 be combined with THBS3 antibody validation for functional studies?

CRISPR-Cas9 technology provides a powerful complement to THBS3 antibody-based research by enabling precise genetic manipulation of the THBS3 gene. The methodological approach involves several steps: First, researchers design guide RNAs targeting specific exons of the THBS3 gene (e.g., Exon2 and Exon3) . After transfection and selection of edited cells, THBS3 antibodies can be used to confirm knockout efficiency through Western blot and immunofluorescence assays . This validation step is critical to ensure complete abolishment of THBS3 expression. The CRISPR-Cas9 edited cell lines then serve as excellent negative controls for antibody specificity testing - any residual signal in knockout lines may indicate non-specific binding. Additionally, these genetically modified cells become valuable experimental models for investigating THBS3 function. For instance, comparing viral infection rates or cellular behaviors between wild-type and THBS3-knockout cells while using THBS3 antibodies for detection can reveal functional roles of the protein . This combined approach strengthens both the validation of antibody specificity and the functional characterization of THBS3.

What is the role of THBS3 in cell adhesion and how can antibodies help investigate this function?

THBS3 functions as an adhesive glycoprotein that mediates important cell-to-cell and cell-to-matrix interactions by binding to multiple extracellular matrix components including fibrinogen, fibronectin, laminin, and type V collagen . To investigate this adhesion function, researchers can employ several antibody-based methodological approaches. Cell adhesion assays can be performed using surfaces coated with purified matrix proteins, followed by antibody blocking experiments where THBS3 antibodies are used to inhibit THBS3-mediated adhesion. Co-localization studies combining THBS3 antibodies with antibodies against known adhesion receptors (using confocal microscopy) can reveal spatial relationships during adhesion processes. For quantitative analysis, researchers can conduct adhesion strength measurements with and without THBS3 antibody treatment. Additionally, cell migration assays (such as wound healing or transwell migration) combined with THBS3 antibody blocking can demonstrate the functional importance of THBS3 in cell movement. These experimental approaches collectively provide mechanistic insights into how THBS3 contributes to cellular adhesion dynamics in both normal physiology and disease states.

What are the recommended protocols for Western blot analysis using THBS3 antibodies?

For Western blot analysis using THBS3 antibodies, researchers should follow this optimized protocol: Begin with protein extraction using a buffer containing protease inhibitors to prevent degradation of THBS3. Determine protein concentration using Bradford or BCA assay and load 20-50 μg of total protein per lane. Separate proteins on an 8-10% SDS-PAGE gel, as THBS3 has a molecular weight of approximately 37.6 kDa . Transfer proteins to a PVDF or nitrocellulose membrane at 100V for 60-90 minutes in cold transfer buffer. Block the membrane with 5% non-fat milk or BSA in TBST for 1 hour at room temperature. Incubate with primary THBS3 antibody at the recommended dilution (e.g., 1:500 to 1:2000 for CAB3641 ) overnight at 4°C. After washing with TBST (3×10 minutes), incubate with HRP-conjugated secondary antibody (such as Anti-HRP Goat Anti-Rabbit IgG ) at 1:5000 dilution for 1 hour at room temperature. Perform final washes with TBST (3×10 minutes) before developing using ECL substrate and imaging. For validation, include positive control samples known to express THBS3 and consider using THBS3 knockout samples as negative controls when available.

What dilutions and conditions are optimal for ELISA using THBS3 antibodies?

For optimal ELISA performance using THBS3 antibodies, researchers should follow these specific methodological guidelines: Begin by coating high-binding ELISA plates with capture antibody or recombinant THBS3 protein (if performing a competitive ELISA) at 1-2 μg/ml in carbonate-bicarbonate buffer (pH 9.6) overnight at 4°C. Block remaining binding sites with 2-5% BSA in PBS for 1-2 hours at room temperature. For direct ELISA, apply samples and standards to the plate in dilution buffer (PBS with 0.05% Tween-20 and 1% BSA). For sandwich ELISA, use a second detection antibody after sample incubation. When using THBS3 antibodies like PACO30378, which has been validated for ELISA applications , start with a dilution range of 1:500 to 1:2000 in dilution buffer and optimize based on signal-to-noise ratio. Incubate for 1-2 hours at room temperature or overnight at 4°C for maximum sensitivity. After washing (PBS with 0.05% Tween-20, 4-5 times), apply appropriate HRP-conjugated secondary antibody and develop with TMB substrate. The reaction can be stopped with 2N H₂SO₄ and absorbance read at 450nm. Include a standard curve using recombinant THBS3 protein for quantification and appropriate negative controls to establish assay specificity.

How should immunofluorescence experiments be designed when using THBS3 antibodies?

For immunofluorescence experiments with THBS3 antibodies, researchers should implement the following methodological approach: Begin by growing cells on sterile glass coverslips until they reach 50-70% confluence. Fix cells with 4% paraformaldehyde for 15 minutes at room temperature, then permeabilize with 0.1-0.5% Triton X-100 in PBS for 5-10 minutes if intracellular detection is required (note that THBS3 functions in the extracellular matrix, so membrane permeabilization protocols should be optimized accordingly). Block non-specific binding with 5% normal serum (from the same species as the secondary antibody) in PBS with 1% BSA for 30-60 minutes. Incubate with primary THBS3 antibody at optimized dilutions (typically starting at 1:100-1:500) in blocking buffer overnight at 4°C. After washing with PBS (3×5 minutes), apply fluorophore-conjugated secondary antibody (such as Anti-FITC Goat Anti-Rabbit IgG ) at 1:200-1:1000 dilution for 1 hour at room temperature in the dark. For nuclear counterstaining, include DAPI (1:1000) during the final 5-10 minutes of secondary antibody incubation. After final washes, mount coverslips using anti-fade mounting medium. For co-localization studies, combine THBS3 antibody with antibodies against potential binding partners or cellular markers, using differentially labeled secondary antibodies. Image using confocal microscopy to obtain high-resolution visualization of THBS3 localization patterns.

What approaches can be used to validate the specificity of THBS3 antibodies?

Validating THBS3 antibody specificity requires a multi-faceted approach to ensure reliable experimental results. First, researchers should conduct Western blot analysis to confirm that the antibody detects a protein of the expected molecular weight (approximately 37.6 kDa for THBS3 ). Genetic validation through CRISPR-Cas9-mediated THBS3 knockout cells provides one of the most stringent specificity tests - the antibody signal should be absent or dramatically reduced in knockout samples . Peptide competition assays, where the antibody is pre-incubated with excess recombinant THBS3 protein before sample detection, can demonstrate binding specificity. If the signal disappears after peptide competition, this indicates specific recognition. RNA interference (siRNA or shRNA targeting THBS3) offers another validation approach, where knockdown efficiency can be correlated with antibody signal reduction. Testing the antibody across multiple techniques (Western blot, immunofluorescence, and ELISA) helps confirm consistent target recognition. Finally, cross-reactivity testing in cells from different species can verify species specificity claims, such as the mouse and rat reactivity noted for CAB3641 or mouse reactivity for PACO30378 .

How can researchers troubleshoot weak or non-specific signals when using THBS3 antibodies?

When encountering weak or non-specific signals with THBS3 antibodies, researchers should systematically troubleshoot using the following methodological approach: For weak signals, first optimize antibody concentration by testing a dilution series (e.g., 1:200, 1:500, 1:1000, 1:2000). Extend primary antibody incubation time to overnight at 4°C to enhance sensitivity. For Western blots, increase protein loading (50-75 μg) and use enhanced chemiluminescence substrates with longer exposure times. Consider alternative epitope retrieval methods for fixed tissues or cells, such as heat-induced retrieval in citrate buffer. For non-specific signals, implement more stringent blocking conditions using 5% BSA instead of milk, or add 0.1-0.3% Triton X-100 to reduce hydrophobic interactions. Increase washing duration and frequency (5×10 minutes with TBST). Test alternative secondary antibodies, as some may exhibit cross-reactivity. If background persists, pre-absorb the primary antibody with cell/tissue lysate from a species different from the target. For both issues, compare results with alternative THBS3 antibodies that recognize different epitopes, such as comparing PACO30378 with CAB3641 , to identify the most specific and sensitive option for your experimental system.

What factors affect the interpretation of THBS3 expression data in disease models?

Interpreting THBS3 expression data in disease models requires careful consideration of several confounding factors. First, tissue heterogeneity significantly impacts results - THBS3 expression may vary between cell types within the same tissue, necessitating single-cell or cell-specific isolation approaches before analysis. Second, THBS3 exists in both cell-associated and secreted forms, requiring researchers to analyze both cellular lysates and conditioned media/extracellular matrix fractions for complete expression profiles. Post-translational modifications, including glycosylation, may affect antibody recognition and apparent molecular weight, so researchers should use deglycosylation enzymes to confirm target identity when unexpected bands appear. Temporal dynamics also influence interpretation - THBS3 expression changes during disease progression, requiring time-course studies rather than single timepoint analyses. When studying disease models, appropriate controls must include both healthy tissues and related disease states to identify disease-specific versus general stress-response changes. Quantification methods matter - researchers should normalize THBS3 signals to stable housekeeping proteins and employ statistical analyses appropriate for the data distribution. Finally, correlation with functional outcomes strengthens interpretation - researchers should link THBS3 expression changes to relevant physiological or pathological parameters to establish biological significance.

How should researchers analyze and interpret THBS3-viral protein interaction data?

Analysis and interpretation of THBS3-viral protein interaction data requires a comprehensive methodological approach encompassing multiple techniques and controls. When investigating interactions between THBS3 and viral proteins such as pseudorabies virus glycoprotein D (PRV gD) , researchers should first establish direct binding using co-immunoprecipitation with THBS3 antibodies followed by immunoblotting for viral proteins, or vice versa. Results should be quantified by densitometry and statistically analyzed across multiple experimental replicates. Interaction specificity can be confirmed through competition assays with soluble THBS3 protein, which should impair PRV infection as measured by reductions in viral plaque number and size . Surface plasmon resonance or microscale thermophoresis provides quantitative binding affinity data (KD values) between purified THBS3 and viral proteins. Functional relevance of interactions should be validated through virus attachment assays comparing THBS3-expressing versus THBS3-knockout cells , with results presented as relative binding percentages normalized to controls. Researchers should also investigate whether THBS3 interactions with viral proteins influence other host receptors, such as Nectin-1 in PRV infection . Finally, microscopy techniques including confocal imaging or proximity ligation assays can visualize co-localization in situ, providing spatial context for the interaction during viral attachment and entry stages.

What statistical approaches are appropriate for analyzing THBS3 antibody experimental data?

When analyzing THBS3 antibody experimental data, researchers should select appropriate statistical approaches based on experimental design, data distribution, and research questions. For comparing THBS3 expression between two conditions (e.g., treated vs. untreated), Student's t-test is appropriate for normally distributed data, while Mann-Whitney U-test should be used for non-parametric data. Multiple group comparisons require ANOVA with appropriate post-hoc tests (Tukey's or Dunnett's) to control for family-wise error rates. For time-course experiments studying THBS3 expression dynamics, repeated measures ANOVA or mixed-effects models are most suitable. Correlation studies examining relationships between THBS3 levels and other parameters should use Pearson's (parametric) or Spearman's (non-parametric) correlation coefficients. When analyzing the effect of THBS3 antibody blocking on viral infection, researchers should employ dose-response curve analysis with EC50 calculation. Statistical power calculations should be performed a priori to determine appropriate sample sizes for detecting biologically meaningful differences. Finally, researchers should clearly report all statistical parameters including exact p-values, confidence intervals, test statistics, degrees of freedom, and effect sizes to ensure reproducibility and transparent interpretation of THBS3 antibody experimental results.